Evidence map›Paper›PMID 39311332›Full record

ArticlePediatric reports2024

Preferred Treatment Patterns of Retinopathy of Prematurity: An International Survey.

Amy T Wang, Shuan Dai

Abstract read
In one paragraph

Article in Pediatric reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Anti-vascular endothelial growth factor therapies in ophthalmology.Medical hypothesis, discovery & innovation ophthalmology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amy T WangDepartment of Ophthalmology, Queensland Children's Hospital, South Brisbane 4101, Australia.ORCID 0000-0003-2115-129X
Shuan DaiDepartment of Ophthalmology, Queensland Children's Hospital, South Brisbane 4101, Australia.ORCID 0000-0002-7026-8155

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper assesses the preferred treatment patterns for retinopathy of prematurity (ROP) and examine trends in anti-vascular endothelial growth factor (VEGF) use for ROP.

Indexed as

anti-vascular endothelial growth factorintravitreal injectionlaser photocoagulationretinopathy of prematurity

Identifiers

PMID39311332
PMCPMC11417966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.